HealthTell is committed to empowering the next generation of diagnostics and therapeutics for complex immune-mediated diseases such as cancer, autoimmune disorders, and infectious disease.

The HealthTell ImmunoSignatureTM technology measures a person’s real-time response to disease. We analyze the binding patterns of an individual’s antibodies to our proprietary peptide arrays. These binding patterns provide highly accurate insight into the presence and nature of specific diseases.